Compare GTY & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTY | RXRX |
|---|---|---|
| Founded | 1955 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1998 | 2021 |
| Metric | GTY | RXRX |
|---|---|---|
| Price | $32.44 | $3.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $32.60 | $7.50 |
| AVG Volume (30 Days) | 380.1K | ★ 20.1M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | 8.00 | ★ 14.79 |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $221,727,000.00 | $74,681,000.00 |
| Revenue This Year | $9.39 | $12.11 |
| Revenue Next Year | $7.83 | $82.52 |
| P/E Ratio | $75.77 | ★ N/A |
| Revenue Growth | 9.02 | ★ 26.92 |
| 52 Week Low | $25.39 | $2.77 |
| 52 Week High | $34.75 | $7.18 |
| Indicator | GTY | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 48.89 |
| Support Level | $32.06 | $2.88 |
| Resistance Level | $33.99 | $4.01 |
| Average True Range (ATR) | 0.69 | 0.27 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 41.34 | 25.69 |
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.